Nobilis Announces the Acquisition of Intraoperative Neuromonitoring Company

May 05, 2015

HOUSTON, TX--(Marketwired - May 05, 2015) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis") today announced that it has entered into an agreement to acquire Peak Surgeon Innovations, LLC ("Peak"), a provider of intraoperative neuromonitoring ("IOM") services for hospitals, surgery centers and other healthcare facilities. Nobilis will pay $700,000.00 in cash and $800,000.00 in Nobilis common stock, and the seller, Dr. Brian Hasse, will be entitled to receive an earn out based on the service line's EBITDA after 18 months of operations under Nobilis. Dr. Hasse executed an employment agreement with Nobilis naming him the Vice President of Nobilis' new electrodiagnostic division. Through the real-time observation and recording of electrical potentials from the nervous system during surgical operations, IOM helps reduce the risk of damage to the nervous system by providing functional guidance to the surgeon and anesthesiologist.

"With this acquisition, Nobilis has officially launched its new ancillary services division," said Kenneth Efird, Nobilis' Chief Development Officer, "Peak instantly expands our ancillary services into multiple locations across multiple states. We expect to rollout ancillary service lines in toxicology, first assist, DNA testing and anesthesia, among others, over the next few months."

"This acquisition furthers Nobilis strategy of capturing additional per case revenues" said Chris Lloyd, Nobilis' Chief Executive Officer. "We will likely recognize an impact on our cash flow over the next quarter, and as our procedure volume increases, ancillary revenues will materially impact our financials," continued Lloyd.

About Nobilis Health Corp.

Nobilis owns and manages ambulatory and acute care facilities to deliver healthcare services. Our focus is improving access to care and patient outcomes by providing minimally invasive procedures that can be performed in low-cost, outpatient settings. We utilize innovative direct-to-patient marketing and proprietary technologies to drive patient engagement and education, resulting in added surgical volume and outsized returns to investors. Nobilis owns and manages seven surgical facilities in Dallas, Houston, and Scottsdale and has contractual partnerships with six other facilities in Arizona, Oregon, Michigan, Minnesota, Tennessee and New Jersey.

Forward-looking statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com and in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2014, filed on April 2, 2015. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.

Contact Information:
Matthew K. Maruca
Nobilis Health Corp.
General Counsel
713-355-8614 x396
info@nobilishealth.com